Hypera S.A. logo

Hypera S.A.

B3:HYPE3.SA

Overview | Financials
Company Name Hypera S.A.
Symbol HYPE3.SA
Currency BRL
Price 25.94
Market Cap 16,400,764,634
Dividend Yield 3.99%
52-week-range 25.87 - 37.18
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Breno Toledo Pires de Oliveira
Website https://www.hyperapharma.com.br

An error occurred while fetching data.

About Hypera S.A.

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex

Related Stocks

Sartorius Stedim Biotech S.A. logo

Sartorius Stedim Biotech S.A.

DIM.PA

208 EUR

Raia Drogasil S.A. logo

Raia Drogasil S.A.

RADL3.SA

25.34 BRL

Eurofins Scientific SE logo

Eurofins Scientific SE

ERF.PA

56.22 EUR

argenx SE logo

argenx SE

ARGX.BR

441.9 EUR

UCB SA logo

UCB SA

UCB.BR

176.7 EUR

Grifols, S.A. logo

Grifols, S.A.

GRF.MC

9.83 EUR

Fisher & Paykel Healthcare Corporation Limited logo

Fisher & Paykel Healthcare Corporation Limited

FPH.NZ

20.7 NZD

bioMérieux S.A. logo

bioMérieux S.A.

BIM.PA

106.6 EUR

Ipsen S.A. logo

Ipsen S.A.

IPN.PA

116.8 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD